Abbott launches Lingo longevity wearable with continuous ketone tracking

Latest articles

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

It’s time to reboot longevity and healthy aging

Dr Michael Roizen calls for fundamental societal changes to ensure the benefits of longevity and healthy aging are realised. Later this year, best-selling author Michael...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Click the globe for translations.

Abbott pushes the envelope of biowearables as it announces its new tech for tracking ketones biomarkers.

Abbott, the company behind the Freestyle Libre continuous glucose monitor, has announced it is developing a new category of consumer biowearables called Lingo, which is being designed to track key signals in the body – such as glucose, ketones, and lactate – to help people better understand their general health and take action to improve it.

Longevity.Technology: If you can measure it, you can monitor it, and if you can monitor it, you can alter it. Wearables can help the user optimise metabolism and improve the functioning of the body by making lifestyle and dietary changes and continuous glucose monitoring (CGM), which was originally devised for diabetes management, is already popular among the biohacking community, and now Abbot are adding more strings to their monitoring bow, adding in ketone and lactate monitoring. Measuring ketones isn’t new, but Lingo will allow biohackers to dispense with intermittent finger prick tests, urine samples and breath readings and leverage a continuous stream of data.

Ketosis is a metabolic state in which your body uses fat and ketones rather than glucose as its main fuel source. In addition to helping you burn fat, ketosis can make you feel less hungry, and can also help you maintain muscle: a hugely important factor in aging well and longevity. Ketosis leads to a high concentration of ketones in the blood – and this is detectable and trackable.

Launching Lingo at the Consumer Electronics Show, Abbott Chairman and Chief Executive Officer Robert B Ford said: “Technology gives us the power to digitize, decentralize and democratize healthcare, create a shared language between you and your doctor – and put more control of your health in your hands. We’re creating a future that will bring you and your loved ones care that’s more personal and precise. It’s happening right now. And its potential is no less than incredible [1].”

Lingo – tapping into the body’s unique language

Lingo’s sensor technology is being designed to track key signals in the body such as glucose, ketones and lactate, and could also be used one day to track alcohol levels.

“This will be like having a window into your body,” said Ford. “It’s science that you will be able to access any time so you can understand what your body is telling you and what it needs. Our vision is that Lingo will go far beyond today’s wearables for consumers to help you proactively manage your health, nutrition and athletic performance [1].”

Lingo's sensor technology is being designed to track key signals in the body such as glucose, ketones and lactate, and could also be used one day to track alcohol levels.

Lingo is extending the Abbott sensing technology platform that Abbott pioneered in 2014 for people with diabetes, allowing people to continuously monitor their glucose levels with a small sensor on the back of the upper arm. Abbott capitalised on the tech with a platform for athletes – the Libre Sense Glucose Sport Biowearable – used by elite athletes such as marathon world record holder Eliud Kipchoge.

Lingo is aiming to expand glucose monitoring to people looking to manage their weight, sleep better, improve energy and think more clearly. The ketone biowearable is being developed to track ketones continuously, see how quickly the wearer is entering a state of ketosis and understand exactly what keeps them there by providing insights on dieting and weight loss.

In addition, a lactate biowearable is in development to track continuous lactate build up during exercise, which can be used as an indicator of athletic performance.

[1] https://www.prnewswire.co.uk/news-releases/abbott-announces-future-of-biowearables-at-consumer-electronics-show-861556661.html

Photograph: Abbott
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Sugar-proof your health with the GLYLO weight loss and antiaging supplement

Move your New Year's resolution up a gear with GLYLO, a double-action supplement that can increase weight loss while also slowing aging. Choosing an effective...

Related articles

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Omecu aims to reduce analysis time and democratise genome data

Spinout company aims to revolutionise the handling of genome data by drastically reducing the time it takes to analyse millions of genetic records. Omecu Ltd,...

Machine learning robots a step in the right direction for tetraplegic patients

Machine learning enables thought-controlled robots that learn from mistakes. Two Ecole Polytechnique Fédérale de Lausanne (EPFL) research groups teamed up to develop a machine learning...

New partnership to accelerate microbiome analysis with AI augmentation

Eagle Genomics and Quadram Institute’s new strategic partnership set to accelerate microbiome analysis through AI-augmented knowledge discovery platform. Today, Eagle Genomics, the Deep Tech software business...

    Subscribe to our newsletter